UBA6 and cancer: Altogether, these data from immunotherapy-treated cancer patients support the clinical relevance of our experimental findings from mouse tumour models with UBA6 knockout (Fig. 5), suggesting that UBA6 in tumour cells would be a useful target for immunotherapy.